FDA approves new and updated indications for temozolomide under Project Renewal

[FDA]

On September 14, 2023, the Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for older oncology drugs to ensure information is clinically meani


Baca selengkapnya di : http://www.fda.gov...